; group 1 consisted of cases 1 to 10 at each hospital, group 2 was cases 11 to 30, group 3 was cases 31 to 70, group 4 was cases 71 to 150, and group 5 was cases ≥151. We tested whether EVT-CCV group was associated with procedural and clinical outcomes. 
ndovascular thrombectomy (EVT) has been the standard treatment for emergent large vessel occlusion (LVO) since successes of recent randomized trials. [1] [2] [3] [4] EVT procedural volumes for acute stroke have been rapidly expanding worldwide. Because successful EVT trials were conducted at high-volume centers that had efficient and resource-rich stroke systems, 5 the same beneficial effects cannot be always guaranteed at low-volume centers with less experienced practitioners. 6 Previous studies suggested that a larger volume of acute stroke patients at a hospital was associated with lower mortality. [7] [8] [9] Those studies involved all acute stroke patients and have not focused on patients who received endovascular treatment. In contrast, before the modern EVT era, an increased hospital endovascular treatment volume for acute stroke was not associated with lower mortality in a large retrospective cohort, including all Medicare beneficiaries treated from 2007 to 2010 . 10 Because those studies did not access individual patient data, the only outcome analyzed was mortality. In the modern EVT era that used stent retriever (SR) or contact aspiration (CA), the effect of EVT cumulative case volume (EVT-CCV) on outcomes has little been studied and requires further investigation. If EVT-CCV affected outcome of acute stroke patients, it should be considered as one of important factors in setting the regional system of care for acute stroke to provide more patients with beneficial EVT.
The aim of this study was to test whether or not procedural and clinical outcomes would improve with increased EVT-CCV in a large cohort treated with SR or CA thrombectomy as a first-line modality.
Methods

This article adheres to the American Heart Association Journals implementation of the Transparency and Openness Promotion
Background and Purpose-The effect of endovascular thrombectomy (EVT) cumulative case volume (EVT-CCV) on outcomes of acute stroke patients has not been studied. This study investigated whether EVT-CCV was associated with outcomes. Methods-We identified all patients who underwent EVT for anterior circulation large vessel occlusion. Patients who met enrollment criteria were grouped into 5 based on the number of previous cases at each hospital. The number of cases that were recruited from each hospital and then assigned to each group (n) was designed to increase by the function of 10×2
(n-1)
Guidelines. The data that support the findings of this study are available from the corresponding author on reasonable request. The institutional review boards of every participating hospital approved this study and waived the requirement for informed consent for study inclusion because of the retrospective study design.
Patient Enrollment
We identified consecutive patients who underwent EVT with either SR or CA thrombectomy as a first-line treatment for acute ischemic stroke caused by occlusion of relevant intracranial internal carotid artery or middle cerebral artery M1 or proximal M2 segment from prospectively maintained registries at 17 stroke centers between January 2011 and December 2015. This study was initiated by the Korea Health Technology R&D Project in 2016, and the participation in this study was offered to the most of stroke centers of our country where mechanical thrombectomy for emergent LVO was performed in routine practice. As a result, a total of 17 stroke centers participated.
Enrollment criteria were as follows: (1) age ≥18 years, (2) initial National Institutes of Health Stroke Scale score ≥4, (3) direct admission to each participating hospital without hospital-to-hospital transfer, (4) onset-to-puncture time ≤600 minutes, (5) modified Rankin Scale before the qualifying stroke of 0 or 1, (6) recanalization success assessable on catheter angiogram, (7) documented intracranial internal carotid artery or middle cerebral artery M1 or proximal M2 occlusion on computed tomography, magnetic resonance, or catheter angiography, and (8) functional outcomes (modified Rankin Scale, score 0-6) at 3 months±2 weeks were available. Tandem atherosclerotic or dissecting cervical internal carotid artery occlusion accompanied by intracranial LVO was included. Multifocal LVO (bilateral anterior or involvement of both anterior and posterior circulations) was excluded.
EVT Procedure
Patients eligible for intravenous tPA (tissue-type plasminogen activator) treatment had the full dose of tPA (0.9 mg/kg). All EVT procedures were performed under local anesthesia with or without conscious sedation. A 6F shuttle sheath (Cook, Indianapolis, IN) or an 8F to 9F balloon guide catheter (Cello, Covidien, Irvine, CA or Optimo, Tokai Medical Products, Aichi, Japan) was used as a guide catheter. The use of a balloon guide catheter depended on the protocol of each site. Two types of SRs (Solitaire AB/FR; ev3 Irvine, CA or Trevo ProVue; Stryker, CA) were used for SR thrombectomy, and the Penumbra System (Penumbra, Alameda, CA) was predominantly used for CA thrombectomy.
Data Collection and Assessment
All data, including clinical data, laboratory findings, and procedural details, were obtained from prospectively maintained registries for acute stroke at each participating hospital and entered into a predefined case report form. The case report forms were anonymized and sent to a central laboratory. All imaging data, including pretreatment nonenhanced computed tomography with computed tomography angiography or diffusion-weighted magnetic resonance imaging with magnetic resonance angiography, catheter angiograms during EVT, and follow-up computed tomography or magnetic resonance imaging, were anonymized and sent to the central laboratory as digital imaging and communication in medicine files. Two neuroradiologists independently assessed the images for Alberta Stroke Program Early CT Score, and 2 interventional neuroradiologists independently assessed whether recanalization was achieved on the catheter angiograms. The reviewers were blind to the clinical outcome. Recanalization success was defined as modified Thrombolysis In Cerebral Ischemia grade 2b or 3 on the final control angiogram. Discrepant cases were resolved by consensus between raters who were still blind to both the clinical outcome and follow-up computed tomography or magnetic resonance imaging findings.
The rates of recanalization and good outcome were calculated for all patients who fulfilled the enrollment criteria. Recanalization success was defined as modified Thrombolysis In Cerebral Ischemia grade 2b or 3. A good outcome was defined as modified Rankin Scale of 0 to 2 at 3 months.
Grouping of Patients by EVT-CCV
Patients were grouped into 5 based on the consecutive number of previous cases at each hospital. The number of cases that were enrolled from each hospital and then assigned to EVT-CCV group (n) was designed to increase by the function of 10×2 (n-1) . Thus, EVT-CCV group 1 consisted of the first 10 cases (case No. 1-10) at each hospital; group 2, the next 20 cases (case No. 11-30) at each hospital; group 3, the next 40 cases (case No. 31-70) at each hospital; group 4, the next 80 cases (case No. 71-150) at each hospital; and group 5, all cases that case No. was 151 or greater at each hospital ( Figure 1) . Consequently, the number of hospitals which contributed to patient enrollment was smaller in the latter than in the former group because EVT case volume of each hospital was different during the study period. Only 1 or 2 neurointerventionists performed EVT at each participating hospital. Therefore, regardless of hospitals where they were treated, the patients in the latter group would be treated by more likely experienced operators than in the former group.
We tested whether EVT-CCV group was associated with procedural and clinical outcomes.
Statistical Analysis
All statistical analyses were performed with IBM SPSS Statistics version 23 (IBM Corp, Armonk, NY). All categorical variables are presented as number and frequency (%), and continuous variables are presented as mean±SD. Spearman correlation test was used to find the correlation of EVT-CCV group with recanalization, good outcome, symptomatic intracranial hemorrhage (sICH) and mortality. Bivariate correlation analysis was used to find the correlation of EVT-CCV group with door-to-puncture, puncture-to-recanalization, and onsetto-recanalization times. In the univariate analysis, χ 2 test, Fisher exact test, Student t test, and Mann-Whitney U test were used to assess the association of each variable with recanalization and good outcome, as appropriate. Finally, multivariate binary logistic regression analysis was performed to test whether EVT-CCV group was independently associated with recanalization and good outcome. All variables that showed potential association in univariate analyses (P<0.20) were included in a multivariate analysis. In addition, the type of first-line EVT was included in the multivariate analysis to find factors independently associated with recanalization because the type of first-line EVT might be a potential confounding factor affecting the relationship between EVT-CCV group and recanalization. We assessed the model's goodness of fit with the Hosmer and Lemeshow test.
Data Availability
The anonymized data will be available from the corresponding author on reasonable request by any qualified investigator.
Results
A total of 1032 patients underwent EVT for acute stroke caused by LVO in the participating hospitals during the study period. Among them, 955 patients (92.6%; mean age, 67.8±12.0 years; M:F=507:448) fulfilled the enrollment criteria. Comparisons of demographic and clinical characteristics among the groups are summarized in the Table I in the onlineonly Data Supplement. Overall recanvaalization and good outcome rates were 81.3% and 53.9%, respectively.
The median numbers of cases per hospital were 10 in EVT-CCV group 1, 19 in group 2, 26 in group 3, 80 in group 4, and 99 in group 5, respectively. The median numbers of thrombectomy attempts per case were 3 in EVT-CCV group 1, 2 in group 2, 3 in group 3, 3 in group 4, and 2 in group 5, respectively. Table 2 ). Door-to-puncture and puncture-to-recanalization times also negatively correlated with EVT-CCV group (P<0.001 [r=-0.16] for door-topuncture; P=0.001 [r=-0.124] for puncture-to-recanalization; Table 3 ), whereas onset-to-recanalization time showed no significant correlation (P=0.141)
After adjustment, EVT-CCV group remained independently associated with both recanalization (odds ratio, 1.182; 95% CI, 1.029-1.358) and good outcome (odds ratio, 1.187; 95% CI, 1.053-1.337; Tables 4 and 5) .
Discussion
This study demonstrated that (1) increased EVT-CCV positively correlated with recanalization and good outcome rates, (2) negatively correlated with sICH, mortality, and doorto-puncture, and puncture-to-recanalization times, and (3) EVT-CCV group was independently associated with both recanalization success and good outcome.
Recent successful trials proved that EVT benefits acute stroke patients with LVO.
1-3 Consequently, EVT procedural volumes for acute stroke have been rapidly expanding worldwide.
Approximately 10 000 EVT procedures were performed in the United States during 2015 with significant potential for increased volume in the near future. 11, 12 In Korea, EVT volume has also rapidly increased from 1103 procedures during 2013 to 2328 procedures during 2015. 13 However, successful modern EVT trials were conducted at high-volume stroke centers that had efficient and resource-rich stroke systems. 5 Therefore, the same effects cannot be guaranteed at low-volume centers with less experienced practitioners. 5, 6 To date, this question has not been resolved and requires further investigation. . Thus, EVT-CCV group 1 consisted of the first 10 cases (case No. 1-10) at each hospital; group 2, the next 20 cases (case No. 11-30) at each hospital; group 3, the next 40 cases (case No. 31-70) at each hospital; group 4, the next 80 cases (case No. 71-150) at each hospital; and group 5, all cases that case No. was 151 or greater at each hospital. Therefore, in the first EVT-CCV group, the cases were enrolled from every participating hospital. The number of hospitals which contributed to patient enrollment was smaller in the latter than in the former group because EVT case volume of each hospital was different during the study period. Previous studies have demonstrated that lower-volume centers had worse outcomes than higher-volume centers in carotid artery stenting, coil embolization for intracranial aneurysm, and percutaneous coronary intervention. [14] [15] [16] This trend may also be true for modern EVT for acute stroke, but that question has not yet been addressed. Previous studies suggested that larger hospital stroke case volume has been associated with better outcomes. [7] [8] [9] In those studies, however, all acute stroke patients were included rather than focusing on patients who received endovascular treatment. In a study focusing on endovascular treatment before the modern EVT era, increased hospital volume of endovascular stroke treatment was not associated with lower mortality in a large retrospective cohort study, including all Medicare beneficiaries treated from 2007 to 2010. 10 However, those previous studies did not access an individual patient data, including recanalization and functional outcome, so only mortality as outcome was analyzed. Only 1 study documented procedural and clinical outcomes, which recruited patients treated from September 2009 to July 2011 in the United States. That study documented that higher-volume centers (>50 intraarterial treatments for acute stroke annually) had better recanalization and clinical outcomes. 17 However, the era of modern EVT dates back to the availability of the SR and CA thrombectomy around 2012 in the United States. 6 Studies using data from before this era may not be applied to the modern EVT era. Limited data are available to evaluate the association between operator experience or hospital EVT case volumes and outcomes from this time period. One nationwide in-patient survey database in the United States documented an association between higher EVT volumes and reduced mortality. 18 Another recent study demonstrated that mortality rates were significantly lower in high-volume centers (≥35.2 EVT per year) than in medium or low-volume centers. Furthermore, mortality was significantly lower for patients transferred to high-volume centers than for those admitted directly to low-volume centers. These findings may suggest that the benefits of treatment at a high-volume center outweigh any consequences related to transfer delays. 19 However, those studies also only assessed mortality because individual patient data were not accessible.
In this study, we evaluated the effect of EVT-CCV on outcomes based on individual patient data from the prospectively maintained registries at multiple stroke centers nationwide. EVT-CCV group cannot simply translate to a hospital EVT case volume. The first group recruited cases from every participating hospital, whereas the number of hospitals which contributed to patient enrollment gradually decreased in the latter EVT-CCV groups because EVT case volume of each hospital was different during the study period. Only 1 or 2 neurointerventionists performed EVT at each participating hospital. Therefore, regardless of hospitals where patients were treated, the patients in the latter group would be treated by more likely experienced operators than in the former group. This unique grouping method likely reflected on the experience of the human resources for EVT at each hospital better than simple grouping of hospitals by each hospital case volume per year. That assumption seemed to be rationalized indirectly by the results that recanalization rate positively and puncture-to-recanalization time negatively correlated with EVT-CCV group. In addition, door-to-puncture time negatively correlated with increased EVT-CCV. It suggests that workflow of EVT for acute stroke at each hospital also improved with increased EVT-CCV, which might partly contribute to better outcomes. When inferred from the grouping method, this study might reflect the effect of each operator's or hospital's CCV on outcomes more than those of the other factors. However, it does not mean each operator's or hospital's CCV is more important in outcomes than the other factors, including patient factors. In addition, post-thrombectomy critical care and nursing management can be equally important in functional outcome. However, it can also be assumed that those hospital characteristics are probably better in high case volume than in low case volume centers. 20 The variables that are representative of the procedural and clinical outcome are affected by many factors in addition to EVT-CCV indicates endovascular thrombectomy cumulative case volume; ICH, intracranial hemorrhage; and r, correlation coefficient. How to provide more acute stroke patients with modern EVT remains a subject of debate and investigation. Considering that EVT-CCV was independently associated with procedural and clinical outcomes, the threshold of 12 EVTs per year suggested by the Joint Committee seems to be low for the operator's proficiency in EVT for acute stroke. 21 The regional system of care for acute stroke should be optimized because EVT resources and patient transfer systems differ by country or region. The results of this study suggest that EVT-CCV should be considered as one of important factors in setting the regional system of care for acute stroke.
This study has some strengths and limitations. Although it had retrospective nature, the study population represented ≈13% of all real-world patients who underwent EVT in Korea during the study period on the basis of nationwide data from the Health Insurance Review and Assessment Service. 13 Therefore, the results might represent the effects of EVT-CCV on outcomes in real-world practice. Almost all previous studies used the data extracted from in-patient databases by using International Classification of Diseases codes. Therefore, they did not access individual procedural or functional outcomes; thus, they evaluated the association between hospital case volume and mortality as the only outcome. In the present study, essential information on each individual patient was available, and the association of EVT-CCV with procedural and clinical outcomes, as well as mortality could be analyzed in detail. Since we introduced the unique concept of CCV for grouping, it would likely reflect the experiences of operators at each hospital rather than grouping was done by each hospital case volume per year.
In addition to selection bias inherent to retrospective nature, ≈7.4% of patients were excluded from the analysis because of strict inclusion criteria, which might have affected the results. Of clinical and demographic factors, proportions of male, hypertension, and use of IV-tPA differed among the EVT-CCV groups (Table I in the online-only Data Supplement). However, in contrast with procedural and clinical outcomes, those factors did not show a significant trend across the groups and, therefore, less likely affected the results. Furthermore, baseline National Institutes of Health Stroke Scale and Alberta Stroke Program Early CT Score were not different among the groups. Therefore, the results of this study could provide reference data for planning regional system of care for acute stroke, which is one of the most important issues in the era of modern EVT.
Conclusions
With increased EVT-CCV, recanalization and good outcome rates increased, whereas sICH and mortality rates and doorto-puncture and puncture-to-recanalization times decreased. Increased EVT-CCV was independently associated with both recanalization and good outcome, which should be considered in the setting of regional system of care for acute stroke.
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